摘要:
The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.
摘要:
A probe for monitoring groundwater flow seepage velocity and direction has an electrical heater and a plurality of temperature sensors located equidistant from the heater. The probe with the heater and temperature sensors is lowered into a monitoring well and positioned so as to be immersed in the groundwater. Energy is sent to the heater, and the temperature response at the temperature sensors is measured and recorded. From the measured response to temperature, the groundwater flow velocity and direction are computed and recorded. The temperature sensors may be resistance temperature detectors, thermocouples, or any other state-of-the-art temperature sensing device.
摘要:
The invention herein is directed to an improved thromboplastin composition wherein the thromboplastin is supplied in a tablet separate from calcium salts in order to stabilize the thromboplastin.
摘要:
The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.
摘要:
The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.